Drawing for JHP PHARMACEUTICALS

USPTO serial 77977347

JHP PHARMACEUTICALS

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
CARROLL, DORITT
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with JHP PHARMACEUTICALS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

David M. Perry

DAVID M. PERRY BLANK ROME LLP1 LOGAN SQ FL 9PHILADELPHIA, PA 19103-6998UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the treatment of eye diseases and conditionsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jan 9, 2012MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jan 9, 2012ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jun 11, 2011EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 10, 2011EX5GSOU EXTENSION 5 GRANTED—
Jun 1, 2011EXT5SOU EXTENSION 5 FILED—
Jun 1, 2011EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 9, 2010EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 8, 2010EX4GSOU EXTENSION 4 GRANTED—
Nov 3, 2010EXT4SOU EXTENSION 4 FILED—
Nov 3, 2010EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 1, 2010EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Apr 30, 2010EX3GSOU EXTENSION 3 GRANTED—
Apr 27, 2010EXT3SOU EXTENSION 3 FILED—
Apr 27, 2010EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 7, 2009EX2GSOU EXTENSION 2 GRANTED—
Nov 30, 2009EXT2SOU EXTENSION 2 FILED—
Nov 30, 2009EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 9, 2009EX1GSOU EXTENSION 1 GRANTED—
Jun 9, 2009DPCCDIVISIONAL PROCESSING COMPLETE—
Jun 8, 2009AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
May 13, 2009EXT1SOU EXTENSION 1 FILED—
May 13, 2009DRRRDIVISIONAL REQUEST RECEIVED—
May 13, 2009MAILPAPER RECEIVED—
Dec 9, 2008NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Sep 16, 2008PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 27, 2008NPUBNOTICE OF PUBLICATION—
Aug 13, 2008PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Aug 13, 2008ALIEASSIGNED TO LIE—
Aug 7, 2008CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 7, 2008XAECEXAMINER'S AMENDMENT ENTERED—
Aug 7, 2008GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Aug 7, 2008GNEAEXAMINERS AMENDMENT E-MAILED—
Aug 7, 2008CNEAEXAMINERS AMENDMENT -WRITTEN—
Mar 11, 2008GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 11, 2008GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 11, 2008CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 11, 2008DOCKASSIGNED TO EXAMINER—
Dec 4, 2007NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance